4.8 Article

Bolaamphiphiles as carriers for siRNA delivery: From chemical syntheses to practical applications

Journal

JOURNAL OF CONTROLLED RELEASE
Volume 213, Issue -, Pages 142-151

Publisher

ELSEVIER
DOI: 10.1016/j.jconrel.2015.06.041

Keywords

Bolaamphiphiles; Molecular dynamics simulations; Cryo-EM; FRET; siRNA drug delivery; RNAi induced gene silencing

Funding

  1. CCR NIH HHS [HHSN261200800001C] Funding Source: Medline
  2. Intramural NIH HHS [ZIA BC011061-08] Funding Source: Medline
  3. NCI NIH HHS [HHSN261200800001E] Funding Source: Medline
  4. NIGMS NIH HHS [P41 GM103832, P41GM103832] Funding Source: Medline
  5. PHS HHS [HHSN 261200800001E] Funding Source: Medline

Ask authors/readers for more resources

In this study we have investigated a new class of cationic lipids - bolaamphiphiles or bolas - for their ability to efficiently deliver small interfering RNAs (siRNAs) to cancer cells. The bolas of this study consist of a hydrophobic chain with one or more positively charged head groups at each end. Recently, we reported that micelles of the bolas GLH-19 and GLH-20 (derived from vernonia oil) efficiently deliver siRNAs, while having relatively low toxicities in vitro and in vivo. Our previous studies validated that; bolaamphiphiles can be designed to vary the magnitude of siRNA shielding, its delivery, and its subsequent release. To further understand the structural features of bolas critical for siRNAs delivery, new structurally related bolas (GLH-58 and GLH-60) were designed and synthesized from jojoba oil. Both bolas have similar hydrophobic domains and contain either one, in GLH-58, or two, in GLH-60 positively charged head groups at each end of the hydrophobic core. We have computationally predicted and experimentally validated that GLH-58 formed more stable nano sized micelles than GLH-60 and performed significantly better in comparison to GLH-60 for siRNA delivery. GLH-58/siRNA complexes demonstrated better efficiency in silencing the expression of the GFP gene in human breast cancer cells at concentrations of 5 mu g/mL, well below the toxic dose. Moreover, delivery of multiple different siRNAs targeting the HIV genome demonstrated further inhibition of virus production. Published by Elsevier B.V.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available